Mineralys Therapeutics (MLYS)'s 30-day implied volatility (IV30) was 40.5% at the close on October 23, 2026, down from 56.7% the day before, against a 52-week range of 42.0% to 131.5%. Its 20-day historical volatility was 60.1%.
Data as of October 23, 2026.